Ramdevbaba Solvent Limited (NSE:RBS)
85.20
-3.80 (-4.27%)
Jun 17, 2026, 3:31 PM IST
Ramdevbaba Solvent Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 8,233 | 9,287 | 6,864 | 6,978 | 5,829 |
Other Revenue | 55.88 | 1.61 | 1.8 | 3.34 | 5.55 |
| 8,288 | 9,288 | 6,866 | 6,981 | 5,834 | |
Revenue Growth (YoY) | -10.77% | 35.28% | -1.64% | 19.65% | 37.49% |
Cost of Revenue | 6,823 | 7,962 | 5,674 | 5,889 | 4,878 |
Gross Profit | 1,465 | 1,326 | 1,192 | 1,091 | 956.12 |
Selling, General & Admin | 123.71 | 110.05 | 96.18 | 65.56 | 83.72 |
Other Operating Expenses | 1,029 | 896.04 | 780.45 | 757.09 | 689.67 |
Operating Expenses | 1,205 | 1,054 | 919.27 | 844.99 | 824.95 |
Operating Income | 259.8 | 271.9 | 272.73 | 246.38 | 131.17 |
Interest Expense | -95.14 | -77.88 | -94.86 | -52.62 | -46.33 |
Interest & Investment Income | - | 8.73 | 1.57 | 0.91 | 0.29 |
Other Non Operating Income (Expenses) | - | -2.73 | -2.28 | -4.13 | -5.52 |
EBT Excluding Unusual Items | 164.66 | 200.02 | 177.15 | 190.54 | 79.61 |
Gain (Loss) on Sale of Investments | - | - | - | 1.68 | - |
Gain (Loss) on Sale of Assets | - | - | - | 0.03 | - |
Pretax Income | 164.66 | 200.82 | 177.15 | 192.77 | 91.95 |
Income Tax Expense | 50.36 | 51.07 | 46.82 | 45.88 | 26.04 |
Earnings From Continuing Operations | 114.3 | 149.75 | 130.33 | 146.89 | 65.92 |
Minority Interest in Earnings | 0.03 | 0.28 | - | - | - |
Net Income | 114.33 | 150.03 | 130.33 | 146.89 | 65.92 |
Net Income to Common | 114.33 | 150.03 | 130.33 | 146.89 | 65.92 |
Net Income Growth | -23.80% | 15.12% | -11.27% | 122.84% | 6.82% |
Shares Outstanding (Basic) | 23 | 22 | 15 | 14 | 14 |
Shares Outstanding (Diluted) | 23 | 22 | 15 | 14 | 14 |
Shares Change (YoY) | 4.60% | 44.27% | 10.11% | - | - |
EPS (Basic) | 5.00 | 6.86 | 8.60 | 10.67 | 4.79 |
EPS (Diluted) | 5.00 | 6.86 | 8.60 | 10.67 | 4.79 |
EPS Growth | -27.11% | -20.23% | -19.40% | 122.77% | 6.91% |
Free Cash Flow | -857.78 | -1,272 | -1,054 | -285.55 | -156.28 |
Free Cash Flow Per Share | -37.52 | -58.19 | -69.58 | -20.75 | -11.36 |
Gross Margin | 17.68% | 14.28% | 17.36% | 15.63% | 16.39% |
Operating Margin | 3.13% | 2.93% | 3.97% | 3.53% | 2.25% |
Profit Margin | 1.38% | 1.62% | 1.90% | 2.10% | 1.13% |
Free Cash Flow Margin | -10.35% | -13.69% | -15.35% | -4.09% | -2.68% |
EBITDA | 312.92 | 320.16 | 315.37 | 268.72 | 182.72 |
EBITDA Margin | 3.77% | 3.45% | 4.59% | 3.85% | 3.13% |
D&A For EBITDA | 53.12 | 48.26 | 42.64 | 22.34 | 51.55 |
EBIT | 259.8 | 271.9 | 272.73 | 246.38 | 131.17 |
EBIT Margin | 3.13% | 2.93% | 3.97% | 3.53% | 2.25% |
Effective Tax Rate | 30.59% | 25.43% | 26.43% | 23.80% | 28.31% |
Revenue as Reported | 8,288 | 9,358 | 6,930 | 7,064 | 5,853 |
Advertising Expenses | - | - | - | - | 0.85 |